Aptamer–Drug Conjugation for Targeted Tumor Cell Therapy

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aptamers developed for applications in cancer therapy can improve the efficacy of drug treatment and enhance molecular imaging. Aptamers for these purposes are generated from SELEX (Systematic Evolution of Ligands by EXponential enrichment), more precisely cell-based SELEX, a process described in detail in this chapter. Experimental applications are also provided for aptamer-based drugs.

Cite

CITATION STYLE

APA

Donovan, M. J., Meng, L., Chen, T., Zhang, Y., Sefah, K., & Tan, W. (2011). Aptamer–Drug Conjugation for Targeted Tumor Cell Therapy. In Methods in Molecular Biology (Vol. 764, pp. 141–152). Humana Press Inc. https://doi.org/10.1007/978-1-61779-188-8_9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free